- Accurate & compact/Easy-to-use
- Rapid immunoassay
- Small sample volume analysis
- Innovative microchip and microfluidic technologies
- Flexible platform for multiple tests
The FREND™ System is a small, fast and near-patient in vitro diagnostic for a measurement of biomarkers in patient samples.
Key Advantage: One drop! 3 minutes!
With a simple 3 step operation and a wide range of disease markers, the system supports quick decision-making. It is expected to increase patients’ satisfaction and a hospital’s profitability by improving the effectiveness the test.
Key Technology: Microfluidics Technology Leader
The FREND™ System is an in vitro diagnostic device that uses microfluidics technology and immunofluorescent techniques. Disposable plastic microfluid chip continuously mixes, reacts, separates, and analysis on the chip. This is a source technology that is the foundation for bioengineering experiments and point-of-care test (POCT).
Excellent Quality Control
Use the QC cartridge to quickly check the integrity of the system. The FREND™ System cleared 510(k) as the in vitro diagnostic (IVD). The code chip significantly reduces possible errors in between test values and LOT variation, hence provides more accurate results.
The FREND™ System received FDA 510(k) clearance as the in-vitro diagnostics which provides a high correlation with large machinery and provides accurate results.
FDA 510(k) clearance
PSA Plus, TSH, Free T4, Testosterone and Vitamin D cleared from FDA 510(k).